Mark T Iwicki Insider Trading $AIMT Aimmune Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Mark T Iwicki.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Mark T Iwicki. Mark T Iwicki is EVP & Chief Commercial Officer in Sunovion Pharmaceuticals Inc. ($SEPR) and Chief Executive Officer in Kala Pharmaceuticals, Inc. ($KALA) and Director in Pulmatrix, Inc. ($PULM) and Director in Aimmune Therapeutics, Inc. ($AIMT) and Director in Akero Therapeutics, Inc. ($AKRO).

Mark T Iwicki in Aimmune Therapeutics, Inc.

Trading Symbol: AIMT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark T Iwicki: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 14 2020
$AIMT Market Capitalization: $796.78M
$AIMT Previous Close: $18.66

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Mark T Iwicki in Aimmune Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AIMT, AKRO, KALA, PULM, SEPR

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Oct 14 2020AIMTAimmune Therapeuti ...Iwicki Mark TDirectorOption ExerciseD17.1115,398263,4600
Oct 14 2020AIMTAimmune Therapeuti ...Iwicki Mark TDirectorOption ExerciseD19.9011,432227,4970
Oct 14 2020AIMTAimmune Therapeuti ...Iwicki Mark TDirectorOption ExerciseD32.797,500245,9250
Oct 14 2020AIMTAimmune Therapeuti ...Iwicki Mark TDirectorOption ExerciseD18.2617,500319,5500
Oct 14 2020AIMTAimmune Therapeuti ...Iwicki Mark TDirectorOption ExerciseD15.4019,755304,2270
Oct 14 2020AIMTAimmune Therapeuti ...Iwicki Mark TDirectorOption ExerciseD6.2987,368549,5450
Oct 14 2020AIMTAimmune Therapeuti ...Iwicki Mark TDirectorOption ExerciseD3.0252,421158,3110
Oct 14 2020AIMTAimmune Therapeuti ...Iwicki Mark TDirectorSellD34.507,840270,48007.8 K to 0 (-100.00 %)
Oct 14 2020AIMTAimmune Therapeuti ...Iwicki Mark TDirectorSellU34.5039,5671,365,062039.6 K to 0 (-100.00 %)
May 29 2020AIMTAimmune Therapeuti ...Iwicki Mark TDirectorOption ExerciseA17.1115,398263,46015,398
May 29 2020AIMTAimmune Therapeuti ...Iwicki Mark TDirectorGrantA0.007,840047,40739.6 K to 47.4 K (+19.81 %)
May 28 2019AIMTAimmune Therapeuti ...Iwicki Mark TDirectorOption ExerciseA19.9011,432227,49711,432
May 28 2019AIMTAimmune Therapeuti ...Iwicki Mark TDirectorGrantA0.006,442039,56733.1 K to 39.6 K (+19.45 %)
May 24 2018AIMTAimmune Therapeuti ...Iwicki Mark TDirectorOption ExerciseA32.797,500245,9257,500
May 24 2018AIMTAimmune Therapeuti ...Iwicki Mark TDirectorGrantA0.003,750033,12529.4 K to 33.1 K (+12.77 %)
Feb 26 2018AIMTAimmune Therapeuti ...Iwicki Mark TDirectorBuyP32.009,375300,00029,37520 K to 29.4 K (+46.88 %)
May 30 2017AIMTAimmune Therapeuti ...Iwicki Mark TDirectorOption ExerciseA18.2617,500319,55017,500
May 27 2016AIMTAimmune Therapeuti ...Iwicki Mark TDirectorOption ExerciseA15.4019,755304,22719,755
Aug 11 2015AIMTAimmune Therapeuti ...Iwicki Mark TDirectorBuyP16.0020,000320,00020,0000 to 20 K

Page:   1